Search

When Dave Norkin was diagnosed at 39 with a rare cancer, he was told he had just months to live. Now, a decade later, he’s surviving — thanks to the emerging field of theranostics, which combines imaging and therapy for a search-and-destroy mission.

… Friday, January 1, 2021 Dave Norkin remembers very clearly the first time he met with MSK physician Diane Reidy-Lagunes. It was his daughter’s birthday. She had just turned 3. Then age 39 and an attorney with the US Navy, Dave had come to see Dr. Reidy-Lagunes after being diagnosed with a gastrointestinal

Taking a cue from smartphone technology, scientists are using face-recognition algorithms to improve RNA interference.

… Friday, May 12, 2017 Summary RNA interference (RNAi) is a technique that geneticists use to study the function of genes. A new software program developed by researchers at the Sloan Kettering Institute and their collaborators uses principles derived from face-detection technology to improve the efficacy

Research findings from Memorial Sloan Kettering Cancer Center (MSK) will be featured in this year’s American Association for Cancer Research (AACR) Annual Meeting press program. The AACR is the oldest and largest professional organization dedicated to advancing cancer research, and the press program highlights cancer research that a panel of AACR experts considers the most significant of the year and deserving of media attention.

… Sunday, April 2, 2017 David Hyman, MD, speaks to a patient David Hyman, MD, speaks to a patient. Research findings from Memorial Sloan Kettering Cancer Center (MSK) will be featured in this year’s American Association for Cancer Research (AACR) Annual Meeting press program. The AACR is the oldest and

An antibody that targets a protein specific to prostate cells can be used to image prostate cancer more clearly and indicate how well drugs are working.

… Thursday, December 29, 2016 Summary Researchers and physicians need better ways to image prostate cancer and monitor the effectiveness of hormone therapy . They demonstrated that an antibody called 11B6 binds to a protein, called hK2, which is secreted only by prostate cells. This could provide a better

Cancer institutions need to be vigilant in their approach to getting patients safely back to the clinic so they don’t further delay life-saving care.

… Friday, July 24, 2020 At the 2020 American Association for Cancer Research (AACR) Virtual Meeting: COVID-19 and Cancer the overarching message echoed throughout the meeting was that cancer is not going away during the COVID- 19 pandemic. Cancer institutions need to be vigilant in their approach to getting

The largest clinical study ever conducted to date of patients with advanced leukemia found that 88 percent achieved complete remissions after being treated with genetically modified versions of their own immune cells.

… Wednesday, February 19, 2014 Genetically Modified T Cells Induced Complete Remissions in 88 Percent of Advanced Leukemia Patients Treated Investigators from Memorial Sloan Kettering Cancer Center have reported more encouraging news about one of the most exciting methods of cancer treatment today. The

Learn about the 19 students who completed the 2019 Summer Undergraduate Research Program (SURP) at the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK).

… Monday, October 14, 2019 Group of people posing for a photo SURP participants celebrate their last day with GSK Dean Michael Overholtzer (back row, fourth from the right) and GSK Associate Dean Linda Burnley (back row, second from the right). Students and teacher mingling GSK Dean Michael Overholtzer

Dr. Tallman will serve a year-long term as President for the American Society of Hematology.

… Friday, January 8, 2021 The American Society of Hematology (ASH) elected Martin S. Tallman, MD , Chief of MSK’s Leukemia Service as their president for a year-long term. As ASH President, Dr. Tallman will work with other members of ASH to provide ongoing advice and counsel to ASH leadership on specific

Memorial Sloan Kettering Cancer Center (MSK) and the Robbins Family Foundation proudly announce the distinguished MSK nurses who were honored with the 2025 Robbins Family Award for Nursing Excellence.

… Friday, May 9, 2025 Memorial Sloan Kettering Cancer Center (MSK) and the Robbins Family Foundation proudly announce the distinguished MSK nurses who were honored with the 2025 Robbins Family Award for Nursing Excellence. The awards coincide with National Nurses Week and are supported by the Robbins Family

Semanti Mukherjee successfully defended her thesis in September 2011. Her project focused on the genetic variants that contribute to the predisposition for and etiology of myeloproliferative neoplasms.

… Tuesday, November 1, 2011 About Semanti Mukherjee’s Dissertation Research Semanti worked on her thesis project under the guidance of  Robert Klein in the Cancer Biology and Genetics Program. Her project focused on the genetic variants that contribute to predisposition for and etiology of myeloproliferative